Hunger For New Drugs, Tech To Drive 2019 Pharma M&A
Bristol-Myers Squibb made headlines this month with its mammoth takeover of Celgene, but the vast majority of dealmaking in the life sciences space this year will be smaller transactions aimed at...To view the full article, register now.
Already a subscriber? Click here to view full article